H. Jensen

发表

Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries.

O. Faergeman, J. Kastelein, L. U. Gerdes, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease

L. Bolund, O. Faergeman, N. Gregersen, 1995, Clinical genetics.

Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100.

O. Faergeman, N. Gregersen, J. Launbjerg, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia

O. Faergeman, F. Civeira, A. Cenarro, 1999 .

LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia

O. Faergeman, J. Refsgaard, N. Gregersen, 2002, Clinical genetics.

Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.

O. Faergeman, S. Juul, L. K. Andersen, 1997, Archives of internal medicine.

Phenotype of Heterozygotes for Low-Density Lipoprotein Receptor Mutations Identified in Different Background Populations

B. Nordestgaard, M. Benn, G. Jensen, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Characterization of a disease‐causing Glu119‐Lys mutation in the low‐density lipoprotein receptor gene in two Danish families with heterozygous familial hypercholesterolemia

L. Bolund, T. Jensen, B. Andresen, 1994, Human mutation.

Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia.

O. Faergeman, B. Raungaard, H. Jensen, 1998, Clinical chemistry.

A common W556S mutation in the LDL receptor gene of Danish patients with familial hypercholesterolemia encodes a transport-defective protein.

K. Kristiansen, L. Bolund, O. Faergeman, 1997, Atherosclerosis.

Allele‐specific measurement of low‐density lipoprotein receptor transcript levels

L. Bolund, H. Eiberg, S. Kolvraa, 1996, Human mutation.

An LDL receptor promoter mutation in a heterozygous FH patient with dramatically skewed ratio between the two allelic mRNA variants

L. Bolund, N. Gregersen, H. Nissen, 1996, Human mutation.

Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia.

O. Faergeman, N. Gregersen, P. Hansen, 1999, Atherosclerosis.

Two novel mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in a Spanish population

N. Gregersen, F. Civeira, J. Ferrando, 1996, Clinical genetics.

The Trp23-Stop and Trp66-Gly mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in Denmark.

O. Faergeman, N. Gregersen, P. Hansen, 1994, Atherosclerosis.

Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia

N. Gregersen, F. Civeira, J. Rodríguez-Rey, 1998 .

Phenotypic characterization of a patient homozygous for the D558N LDL receptor gene mutation

L. Bolund, O. Faergeman, F. Melsen, 1996, Clinical genetics.

Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study

S. Borgquist, H. Jensen, Sixten Harborg, 2022, Lipids in health and disease.

Intronic mutations at splice junctions in the low-density lipoprotein receptor gene.

L. V. Van Gaal, M. Kotze, J. D. de Villiers, 1999, Molecular and cellular probes.

High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing.

O. Faergeman, N. Gregersen, P. Hansen, 1996, Clinical chemistry.

A G‐1‐to‐A acceptor splice site LDLR mutant allele leads to reduced relative transcript levels in patients with heterozygous familial hypercholesterolemia

L. Bolund, O. Faergeman, N. Gregersen, 1996, Clinical genetics.

An alanine29‐serine variant in exon 2 of the low density lipoprotein receptor gene: no association with hypercholesterolemia

N. Gregersen, L. U. Gerdes, P. Hansen, 1994, Clinical genetics.

A new, highly informative Smal polymorphism in intron 7 of the low density lipoprotein receptor (LDLR) gene

L. Bolund, O. Faergeman, S. Kolvraa, 1994 .

A rare silent C to T mutation in exon 7 of the low density lipoprotein receptor (LDLR) gene

L. Bolund, O. Faergeman, N. Gregersen, 1994 .

No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes.

O. Faergeman, N. Gregersen, M. L. Larsen, 2004, Atherosclerosis.

Identification of a novel mutation in exon 13 of the LDL receptor gene causing familial hypercholesterolemia in two Spanish families.

N. Gregersen, F. Civeira, A. Cenarro, 1996, Biochimica et biophysica acta.

Two point mutations (313 + 1G→A and 313 + 1G→T) in the splice donor site of intron 3 of the low‐density lipoprotein receptor gene are associated with familial hypercholesterolemia

N. Gregersen, O. Færgeman, L. Jensen, 1996, Human mutation.

Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia. Mutations in brief no. 135. Online.

N. Gregersen, F. Civeira, J. Rodríguez-Rey, 1998, Human mutation.

An Iranian‐Armenian LDLR frameshift mutation causing familial hypercholesterolemia

O. Faergeman, N. Gregersen, P. Hansen, 1996, Clinical genetics.

The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population.

O. Faergeman, M. L. Larsen, J. Jensen, 2005, Atherosclerosis.

Two mutations in the same low‐density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia

L. Bolund, O. Faergeman, T. Jensen, 1997, Human mutation.

Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100.

O. Faergeman, B. Raungaard, P. Hansen, 2000, Clinical chemistry.

Incidence of the apolipoprotein B-3500 mutation in Denmark.

O. Faergeman, L. U. Gerdes, I. Klausen, 1994, Clinica chimica acta; international journal of clinical chemistry.

Flow Cytometric Assessment of Effects of Fluvastatin on Low‐Density Lipoprotein Receptor Activity in Stimulated T‐Lymphocytes from Patients with Heterozygous Familial Hypercholesterolemia

B. Raungaard, O. Færgeman, H. Jensen, 2000, Journal of clinical pharmacology.

Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia

N. Gregersen, F. Civeira, J. Rodríguez-Rey, 1998 .

Association of coronary heart disease with age‐adjusted aortocoronary calcification in patients with familial hypercholesterolaemia

O. Faergeman, L. U. Gerdes, J. M. Jensen, 2000, Journal of internal medicine.

Flow cytometric assessment of LDL receptor activity in peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia.

O. Faergeman, B. Raungaard, H. Jensen, 1999, Cytometry.